- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Inshorts pockets $60m in funding
The BCC and SIG-backed news aggregator was valued at about $550m in a round led by technology investment firm Vy Capital.
Jul 19, 2021Analysis: Cybereason raises $275m
Softbank enabled the cybersecurity software provider Cybereason to secure crossover financing at a valuation likely to have exceeded $3bn. This year seems set to be a record one for the broader corporate-backed cybersecurity space, with valuations spiking up.
Jul 19, 2021Daily Deal Round Up: July 16, 2021
Greenhouse gas monitor GHGSat boosted a Schlumberger-backed round to $45m while Toyota’s Woven Planet subsidiary is buying spatial intelligence software developer Carmera.
Jul 16, 2021Prime Medicine presents $315m in funding
The gene editing technology developer is the latest spinout emerging out of the lab of David Liu at Broad Institute.
Jul 16, 2021Revolut receives $800m at $33bn valuation
SoftBank Vision Fund 2 and Tiger Global Management provided the cash, increasing the mobile financial services provider's overall funding to over $1.7bn.
Jul 16, 2021Paytm prepares $2.2bn initial public offering
The corporate-backed mobile payments app’s parent company, One97 Communications, has filed to float in an offering set to include $1.1bn of existing share sales.
Jul 16, 2021MS&AD Ventures boosts fund to $200m
MS&AD Holdings has put up an additional $80m for its corporate venture capital vehicle, two years after tripling its original commitment.
Jul 16, 2021Imperative Care imports $260m in series D
Imperative Care boosted its total funding to at least $379m, with Ascension Ventures participating in the stroke care technology provider's series D round.
Jul 16, 2021Restar readies corporate venturing initiative
The semiconductor contract manufacturer’s Restar-SBI Innovation fund will focus on developers of digitalisation and healthcare technologies.
Jul 16, 2021Imago BioSciences bags $134m in upsized IPO
Pharmaron, Celgene, Amgen and Merck & Co-backed Imago BioSciences floated in an IPO today, alongside a private placement transaction featuring Pfizer.
Jul 16, 2021Wugen wraps up $172m series B
Alexandria Venture Investments was among the participants in a series B round for Wugen, which is developing cellular therapeutics for cancer.
Jul 16, 2021Netradyne accelerates to $150m series C
SoftBank Vision Fund 2 led a series C round for the driver safety technology developer at a valuation of almost $1bn that also featured M12.
Jul 16, 2021Featured Content
GCV Powerlist 2026Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.GCV Powerlist 2026
Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
Corporate venture building reportData from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomesCorporate venture building report
Data from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomes
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
